Arun Swaminathan
Corporate Officer/Principal bei COYA THERAPEUTICS, INC.
Profil
Arun Swaminathan is the founder of Lynkogen, Inc. He is currently the Chief Business Development Officer at Coya Therapeutics, Inc. His former positions include Director-Worldwide Brand at Bristol Myers Squibb Co., Head-Marketing at Labcorp Drug Development, Inc., Chief Business & Commercial Officer at Actinium Pharmaceuticals, Inc. from 2021 to 2022, and Chief Business Officer & Senior Vice President at Alteogen, Inc. Dr. Swaminathan received his graduate and doctorate degrees from the University of Pittsburgh.
Aktive Positionen von Arun Swaminathan
| Unternehmen | Position | Beginn |
|---|---|---|
| COYA THERAPEUTICS, INC. | Corporate Officer/Principal | 27.03.2023 |
Ehemalige bekannte Positionen von Arun Swaminathan
| Unternehmen | Position | Ende |
|---|---|---|
| COVANCE INC. | Sales & Marketing | - |
| Lynkogen, Inc. | Chief Executive Officer | - |
| ALTEOGEN INC. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Arun Swaminathan
| University of Pittsburgh | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| ALTEOGEN INC. | Health Technology |
| COYA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
| Lynkogen, Inc. |
